NanoViricides Inc. Share Price

NanoViricides Inc. Share Price

AMEX: NNVC | Micro Cap
$1.17
-$0.07 (-5.26%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NanoViricides Inc. Stock Performance

Open
$1.27
Prev. Close
$1.24
Circuit Range
N/A
Day Range
$1.16 - $1.27
Year Range
$0.86 - $1.90
Volume
2,701
Average Traded
$1.21

NanoViricides Inc. Share Price Today

As of 18 November 2026, NanoViricides Inc.'s share price is $1.17. The stock opened at $1.27, compared to its previous close of $1.24. During today's trading session, NanoViricides Inc.'s share price traded between $1.16 and $1.27, with an average price of $1.21. Over the past 52 weeks, the stock has recorded a high of $1.90 and a low of $0.86. In terms of performance, NanoViricides Inc.'s share price has declined by 34.64% over the last six months and is down 3.70% on a year-on-year basis.

NanoViricides Inc. Share Price Chart

Line chart of the NanoViricides Inc. price trend over the selected period. The price fell overall, ranging from 1.16 to 1.27, ending at 1.17.
$1.16$1.27
L
Show Current Price
H

NanoViricides Inc. Stock Fundamentals & Key Indicators

Market Cap
$17.69M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-94.65%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-24.02%

NanoViricides Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.79-$2.22-$1.99-$2.22
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-24.02%10.36%-11.56%

NanoViricides Inc. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.59-$8.29-$9.47-$8.22
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A3.49%-14.23%13.20%

About NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.

NanoViricides Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.37
$1.16
-15.94%
Oct 2026
$1.27
$1.38
+6.56%
Sep 2026
$1.23
$1.29
+0.78%
Aug 2026
$1.58
$1.28
-16.01%
Jul 2026
$1.38
$1.53
+10.87%
Jun 2026
$1.73
$1.38
-22.91%
May 2026
$1.30
$1.79
+45.53%
Apr 2026
$0.95
$1.23
+32.69%
Mar 2026
$0.99
$0.93
-10.87%
Feb 2026
$0.98
$1.04
+5.37%
Jan 2026
$1.21
$0.99
-11.48%
Dec 2025
$1.14
$1.11
-8.23%

NNVC Share Price FAQs